Akèy › Kansè tete negatif triple › Kentucky › Louisville

Etid klinik pou Kansè tete negatif triple nan Louisville, KY

3 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Louisville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Ap rekriteFaz 1

Norton Cancer Institute, Louisville

Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05983432

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Ap rekriteFaz 3

Norton Healthcare, Inc., Louisville

Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05633654

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Ap rekriteFaz 1

Norton Cancer Institute /ID# 248903, Louisville

Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT05005403

Etid Kansè tete negatif triple nan lòt vil

Lòt etid nan Louisville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.